We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

US-Based Everist Genomics Bucks the Outsourcing Trend

News   May 22, 2012

 
US-Based Everist Genomics Bucks the Outsourcing Trend
 
 
Advertisement
 

RELATED ARTICLES

SARS-CoV-2 Immunity Rapidly Declines Within Months of Infection

News

A recent preprint study indicates that there is a rapid decline in the levels of SARS-CoV-2 neutralizing antibodies during the weeks following initial infection. This raises questions over the potential for re-infection, the effectiveness that may be expected from vaccination and the viable window for antibody testing in disease surveillance.

READ MORE

New Cancer Vaccine Ready for Human Trials

News

A new cancer vaccine, comprised of human antibodies fused with tumor-specific protein, is ready to begin human testing.

READ MORE

Extracellular Vesicles Promote the Spread of Cancer in the Bloodstream

News

A new study sheds light on how extracellular vesicles, which are released by tumor cells into the bloodstream, promote the spread of cancer.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE